[go: up one dir, main page]

NO20034080D0 - Fremgangsmåte og sett for deteksjon av neurodegenerative sykdommer - Google Patents

Fremgangsmåte og sett for deteksjon av neurodegenerative sykdommer

Info

Publication number
NO20034080D0
NO20034080D0 NO20034080A NO20034080A NO20034080D0 NO 20034080 D0 NO20034080 D0 NO 20034080D0 NO 20034080 A NO20034080 A NO 20034080A NO 20034080 A NO20034080 A NO 20034080A NO 20034080 D0 NO20034080 D0 NO 20034080D0
Authority
NO
Norway
Prior art keywords
kit
detection
neurodegenerative diseases
neurodegenerative
diseases
Prior art date
Application number
NO20034080A
Other languages
English (en)
Other versions
NO20034080L (no
Inventor
Michel Geffard
Original Assignee
Gemac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemac filed Critical Gemac
Publication of NO20034080D0 publication Critical patent/NO20034080D0/no
Publication of NO20034080L publication Critical patent/NO20034080L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20034080A 2001-03-16 2003-09-15 Fremgangsmåte og sett for deteksjon av neurodegenerative sykdommer NO20034080L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0103592A FR2822238B1 (fr) 2001-03-16 2001-03-16 Methode et trousse pour le suivi des maladies neurodegeneratives
PCT/FR2002/000927 WO2002075274A2 (fr) 2001-03-16 2002-03-15 Methode et trousse pour le suivi des maladies neurodegeneratives

Publications (2)

Publication Number Publication Date
NO20034080D0 true NO20034080D0 (no) 2003-09-15
NO20034080L NO20034080L (no) 2003-11-14

Family

ID=8861210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034080A NO20034080L (no) 2001-03-16 2003-09-15 Fremgangsmåte og sett for deteksjon av neurodegenerative sykdommer

Country Status (8)

Country Link
US (1) US7195881B2 (no)
EP (1) EP1399743A2 (no)
JP (1) JP2004530871A (no)
CN (1) CN1511258A (no)
CA (1) CA2441170A1 (no)
FR (1) FR2822238B1 (no)
NO (1) NO20034080L (no)
WO (1) WO2002075274A2 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822238B1 (fr) 2001-03-16 2003-08-29 Gemac Methode et trousse pour le suivi des maladies neurodegeneratives
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US7892751B2 (en) * 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
CA2524325C (en) 2003-06-09 2017-08-01 John A. Mcintyre Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
US9557325B2 (en) * 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
US7840270B2 (en) * 2003-07-23 2010-11-23 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US9050005B2 (en) 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
RU2442793C2 (ru) * 2005-11-30 2012-02-20 Эбботт Лэборетриз АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
KR101434935B1 (ko) 2005-11-30 2014-10-01 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의용도
US8676323B2 (en) * 2006-03-09 2014-03-18 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
US20080097153A1 (en) * 2006-08-24 2008-04-24 Ignagni Anthony R Method and apparatus for grasping an abdominal wall
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US9079016B2 (en) * 2007-02-05 2015-07-14 Synapse Biomedical, Inc. Removable intramuscular electrode
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
WO2008144578A1 (en) * 2007-05-17 2008-11-27 Synapse Biomedical, Inc. Devices and methods for assessing motor point electromyogram as a biomarker
US8478412B2 (en) * 2007-10-30 2013-07-02 Synapse Biomedical, Inc. Method of improving sleep disordered breathing
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
EP2603524A1 (en) 2010-08-14 2013-06-19 AbbVie Inc. Amyloid-beta binding proteins
RU2693627C2 (ru) * 2017-11-03 2019-07-03 Общество С Ограниченной Ответственностью "Валента - Интеллект" Комбинации эдаравона для лечения ишемических повреждений мозга
US11471683B2 (en) 2019-01-29 2022-10-18 Synapse Biomedical, Inc. Systems and methods for treating sleep apnea using neuromodulation
FR3094493A1 (fr) * 2019-04-01 2020-10-02 Polyneuros Procédé de détection ou de suivi de l’évolution d’une maladie chronique auto-immune par dosage immunologique
FR3094492A1 (fr) * 2019-04-01 2020-10-02 Polyneuros Procédé de détection ou de suivi de l’évolution d’une maladie chronique dégénérative par dosage immunologique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550799B1 (fr) * 1983-08-17 1986-02-21 Commissariat Energie Atomique Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
BE1006974A3 (fr) * 1993-04-23 1995-02-07 Anda Biolog Sa Procede de detection et/ou de quantification de differentes classes d'immunoglobulines specifiques d'une pathologie comportant une reponse auto-immunitaire.
FR2762602B1 (fr) * 1997-04-28 1999-06-04 Inst Nat Sante Rech Med Moyens pour la detection precoce de pathologies auto-immunes inflammatoires
FR2822238B1 (fr) 2001-03-16 2003-08-29 Gemac Methode et trousse pour le suivi des maladies neurodegeneratives

Also Published As

Publication number Publication date
WO2002075274A2 (fr) 2002-09-26
CN1511258A (zh) 2004-07-07
WO2002075274A3 (fr) 2003-12-11
FR2822238B1 (fr) 2003-08-29
EP1399743A2 (fr) 2004-03-24
CA2441170A1 (en) 2002-09-26
JP2004530871A (ja) 2004-10-07
NO20034080L (no) 2003-11-14
US20040082015A1 (en) 2004-04-29
US7195881B2 (en) 2007-03-27
FR2822238A1 (fr) 2002-09-20

Similar Documents

Publication Publication Date Title
NO20034080D0 (no) Fremgangsmåte og sett for deteksjon av neurodegenerative sykdommer
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
BR0308115B1 (pt) artigo de calÇado e mÉtodo de fabricaÇço de artigo de calÇado
NO20035010D0 (no) Fremgangsmåter og blandinger for analysering av proteiner
NO20033387L (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
IL177308A0 (en) Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
FI20060154L (fi) Neurogeneratiivisten tilojen hoito
DE60305691D1 (de) Gusseisernes inneres Glied und Herstrellungsverfahren dafür
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
EP1578771A4 (en) REMODELING AND GLYCOKON JUGATION OF PEPTIDES
NO20032112L (no) Grensesnitt for visuale og scenegraf
IS8497A (is) Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma
DK1620551T3 (da) Phospholipase og fremgangsmåde til fremstilling deraf
SE0502484L (sv) Behandling av neurodegenerativa tillstånd
NO20044916L (no) Preparater av sulfinylacetamid
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20033251D0 (no) Fremgangsmåte for bestemmelse av den effektive mobilitet og permeabilitet for en formasjon på stedet
NO20044172L (no) Fremgangsmate og system for automatisk planlegging av eksperimenter
NO20053874D0 (no) Formulering og metoder for behandling av thrombocytemi
NO20034531D0 (no) Brönnbetjeningsfluid og fremgangsmåte for fremstilling og anvendelse av dette
AU2003259833A8 (en) Methods of treating neurodegenerative diseases
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika
DK1639107T3 (da) Forbedrede proteaser og fremgangsmåder til fremstilling deraf
NO20054346D0 (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application